US patients sue Ozempic, Mounjaro makers over vision loss
Dozens of patients have filed lawsuits in the United States against the makers of popular GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, alleging that the medicines caused a rare form of sudden vision loss. GLP-1 drugs are mainly used to treat type 2 diabetes, while some are also approved for ...
Sentiment: Positive (
0.80
)
Bias: Neutral
Fact-Checked Information
Source:
Google Fact Check Tools
Reliability:
Unknown
Notes:
No fact-checks found for this content
Verified on Sep 24, 2026